miR-222 attenuates cisplatin-induced cell death by targeting the PPP2R2A/Akt/mTOR Axis in bladder cancer cells

miR-222 Overexpression May Contribute to Liver Fibrosis in Biliary Atresia by Targeting PPP2R2A

(2015) Rui Dong et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells

(2015) Fen Hu et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance

(2015) Jesús García-Cano et al.   Oncotarget

AKT hyper-phosphorylation associated with PI3K mutations in lymphatic endothelial cells from a patient with lymphatic malformation

(2014) Elisa Boscolo et al.   ANGIOGENESIS

microRNA-222 modulates liver fibrosis in a murine model of biliary atresia

(2014) Wen-jun Shen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Anti-tumor effect of a novel PI3-kinase inhibitor, SF1126, in 12 V-Ha-Ras transgenic mouse glioma model

(2014) Alok R Singh et al.   Cancer Cell International

Downregulation of miR-221/222 enhances sensitivity of breast cancer cells to tamoxifen through upregulation of TIMP3

(2014) R Gan et al.   CANCER GENE THERAPY

MicroRNA-222 Expression and Its Prognostic Potential in Non-Small Cell Lung Cancer

(2014) Kai-ping Mao et al.   TheScientificWorldJOURNAL

MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway

(2014) Yongqiang Dong et al.   TUMOR BIOLOGY

Increased expression of miR-222 is associated with poor prognosis in bladder cancer

(2014) Dong-qing Zhang et al.   World Journal of Surgical Oncology

PI3K/AKT pathway activation in bladder carcinogenesis

(2013) Julien Calderaro et al.   INTERNATIONAL JOURNAL OF CANCER

miR-221/222: promising biomarkers for breast cancer

(2013) Wei-Xian Chen et al.   TUMOR BIOLOGY

PP2A-Mediated Anticancer Therapy

(2013) Weibo Chen et al.   Gastroenterology Research and Practice

miR-143, miR-222, and miR-452 Are Useful as Tumor Stratification and Noninvasive Diagnostic Biomarkers for Bladder Cancer

(2012) Patricia Puerta-Gil et al.   AMERICAN JOURNAL OF PATHOLOGY

Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells

(2012) Susanta Kar et al.   APOPTOSIS

PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing

(2012) R Zimmerman et al.   Cell Death & Disease

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

(2011) M. Garofalo et al.   CURRENT MOLECULAR MEDICINE

Potential role of Hsp90 inhibitors in overcoming cisplatin resistance of bladder cancer-initiating cells

(2011) Manabu Tatokoro et al.   INTERNATIONAL JOURNAL OF CANCER

High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells

(2011) Yunzhi Zhang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling

(2010) Q. W-L. Wong et al.   CLINICAL CANCER RESEARCH

 -Tocopheryl succinate and derivatives mediate the transcriptional repression of androgen receptor in prostate cancer cells by targeting the PP2A-JNK-Sp1-signaling axis

(2009) P.-H. Huang et al.   CARCINOGENESIS

Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activity

(2009) C H Switzer et al.   ONCOGENE

MiRNA expression in urothelial carcinomas: Important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31

(2008) Srinivas Veerla et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer

(2008) Jian-Jun Zhao et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

(2008) M Garofalo et al.   ONCOGENE